CD274 and neoplasm: The PD-1/PD-L1 interaction of T cells and tumour cells leads to the inhibition of the effector function of T cells, therefore blocking this interaction has the potential to significantly enhance the anti-tumour activity of T cells and to reduce T-cell exhaustion.